Dale E Robinson

Title: The Innovative Contributions of Dale E Robinson

Introduction

Dale E Robinson is a notable inventor based in San Diego, California. She has made significant contributions to the field of cancer research through her innovative inventions. With a total of three patents to her name, Robinson's work focuses on the development of anticancer agents that target specific enzymatic processes.

Latest Patents

Robinson's latest patents revolve around anticancer agents based on the prevention of protein prenylation. Prenylating enzymes play a crucial role in modifying oncoproteins, such as RAS, which can lead to uncontrolled growth of neoplastic cells. By inactivating these enzymes, it is possible to prevent this uncontrolled growth. Her research highlights the use of α-dicarbonyl compounds to covalently modify and inactivate prenylating enzymes, including protein farnesyltransferase and protein geranylgeranyltransferase. These compounds can be designed to enhance affinity and specificity for particular protein substrates, showcasing Robinson's innovative approach to cancer treatment.

Career Highlights

Throughout her career, Robinson has worked with esteemed organizations such as the Arizona Disease Control Research Commission and the Arizona Biomedical Research Commission. Her experience in these institutions has allowed her to contribute significantly to the field of biomedical research.

Collaborations

Robinson has collaborated with notable colleagues, including Seth David Rose and Steven R Ottersberg. These partnerships have further enriched her research and development efforts in the field of cancer therapeutics.

Conclusion

Dale E Robinson's innovative work in developing anticancer agents demonstrates her commitment to advancing medical science. Her patents reflect a deep understanding of enzymatic processes and their implications for cancer treatment. Robinson's contributions are paving the way for future advancements in cancer research and therapy.